Zobrazeno 1 - 10
of 69
pro vyhledávání: '"Serge Gauthier"'
Autor:
Yu Kong, Donglai Jing, Min Chu, Bo Cui, Lin Wang, Lin Liu, Hong Ye, Serge Gauthier, Liyong Wu, Jingjuan Wang, Pedro Rosa-Neto, Kexin Xie, Junjie Li, Yue Cui, Li Liu, Jing Zhang
Publikováno v:
Journal of Alzheimer's Disease
Background: The anterior cingulate cortex (ACC) seems to play an important role in behavioral deficits and executive dysfunctions in patients with behavioral variant frontotemporal dementia (bvFTD), while its specific and independent contribution req
Autor:
Else Huyck, Manu Vandijck, Andrea I Benet, Ondrej Lerch, Serge Gauthier, Martin Vyhnalek, Jakub Hort, Katerina Sheardova, Marcel M. Verbeek, Lucilla Parnetti, Alberto Lleó, Daniel Alcolea, Mira Chamoun, Jenna Stevenson, Nicholas J. Ashton, Tharick A. Pascoal, Katerina Cechova, Roberta Rinaldi, Pedro Rosa-Neto, Kaj Blennow, Samuela Cataldi, Ulf Andreasson, Johan Gobom, Giovanni Bellomo, Henrik Zetterberg, Jan Laczó, Neserine Rahmouni, Nathalie Le Bastard, Marcus Clarin
Publikováno v:
Clinical Chemistry and Laboratory Medicine, 60, 207-219
CLINICAL CHEMISTRY AND LABORATORY MEDICINE
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Clinical Chemistry and Laboratory Medicine, 60, 2, pp. 207-219
CLINICAL CHEMISTRY AND LABORATORY MEDICINE
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Clinical Chemistry and Laboratory Medicine, 60, 2, pp. 207-219
Objectives The core cerebrospinal fluid (CSF) biomarkers; total tau (tTau), phospho-tau (pTau), amyloid β 1-42 (Aβ 1-42), and the Aβ 1-42/Aβ 1-40 ratio have transformed Alzheimer’s disease (AD) research and are today increasingly used in clinic
Autor:
Robert Laforce, Jean-Paul Soucy, Simon Ducharme, Joshua A Sonnen, Pedro Rosa-Neto, Tharick A. Pascoal, Serge Gauthier, Melissa Savard, Jake P Levy, Elizabeth Finger, Gleb Bezgin
Publikováno v:
Neuroscience Institute Publications
Tau is one of several proteins associated with frontotemporal dementia. While knowing which protein is causing a patient’s disease is crucial, no biomarker currently exists for identifying tau in vivo in frontotemporal dementia. The objective of th
Autor:
Cheryl R. McCreary, Serge Gauthier, Richard Frayne, Michael Borrie, Sandra E. Black, Simon Duchesne, Eric E. Smith, Richard Camicioli, Victor Whitehead, Fuqiang Gao, Feryal Saad
Publikováno v:
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. :1-8
Objective: To describe the neuroimaging and other methods for assessing vascular contributions to neurodegeneration in the Comprehensive Assessment of Neurodegeneration and Dementia (COMPASS-ND) study, a Canadian multi-center, prospective longitudina
Autor:
Pedro Rosa-Neto, Mira Chamoun, Sulantha Mathotaarachchi, Aurélie Labbe, Michael Schöll, Alzheimer’s Disease Neuroimaging Initiative, Andrea Lessa Benedet, Melissa Savard, Eduardo R. Zimmer, Nicholas J. Ashton, Henrik Zetterberg, Joseph Therriault, Tharick A. Pascoal, Kaj Blennow, Serge Gauthier, Min Su Kang, Antoine Leuzy
Publikováno v:
Brain. 143:3793-3804
Neurofilament light (NfL) is a marker of neuroaxonal injury, a prominent feature of Alzheimer’s disease. It remains uncertain, however, how it relates to amyloid and tau pathology or neurodegeneration across the Alzheimer’s disease continuum. The
Autor:
Sophie E.M. van den Brink, Laila El Amrani, Paolo Vitali, Serge Gauthier, Pedro Rosa-Neto, Joseph Therriault
Publikováno v:
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 48:312-320
Background:In Canada, standard dementia workup consists of clinical, neurological, and cognitive evaluation, as well as structural brain imaging. For atypical dementia presentations, additional FDG-PET brain imaging is recommended. Cerebrospinal flui
Autor:
Sylvie Belleville, Andréa C. LeBlanc, Marie‐Jeanne Kergoat, Frédéric Calon, Pierrette Gaudreau, Sébastien S. Hébert, Carol Hudon, Nicole Leclerc, Naguib Mechawar, Simon Duchesne, Serge Gauthier, Consortium for the Early Identification of Alzheimer's disease‐Quebec (CIMA‐Q), Pierre Bellec, Christian Bocti, Howard Chertkow, Louis Collins, Stephen Cunnane, Carol Hudon Marie‐Jeanne‐Kergoat, Natalie Philips, Jean‐Paul Soucy, Thien Thanh Dang Vu, Louis Verret, Juan Manuel Villalpando
Publikováno v:
Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, Vol 11, Iss 1, Pp 787-796 (2019)
Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring
Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring
Introduction The Consortium for the early identification of Alzheimer's disease–Quebec (CIMA-Q) created a research infrastructure to recruit, characterize, and track disease progression in individuals at risk of dementia. Methods CIMA-Q established
Autor:
Serge Gauthier, Pedro Rosa-Neto, Emilie Thomas, Cecile Tissot, Tharick A. Pascoal, Sulantha Mathotaarachchi, Andrea Lessa Benedet, Mira Chamoun, Ziad S. Nasreddine, Firoza Z. Lussier, Marlee Parsons, Joseph Therriault, Melissa Savard
Publikováno v:
Alzheimer's & Dementia : Translational Research & Clinical Interventions
Alzheimer’s & Dementia: Translational Research & Clinical Interventions, Vol 7, Iss 1, Pp n/a-n/a (2021)
Alzheimer’s & Dementia: Translational Research & Clinical Interventions, Vol 7, Iss 1, Pp n/a-n/a (2021)
Background Neuropsychiatric symptoms (NPS) are frequent in aging and Alzheimer's disease (AD). Here we study the relationship between NPS and AD pathologies in vivo. Method Two hundred and twenty‐one individuals from the TRIAD cohort (143 cognitive
Autor:
William S. Brooks, Ivonne Jimenez-Velazques, Jérémie Pariente, Andrei G. Vlassenko, William E. Klunk, Robert A. Koeppe, Serge Gauthier, Smiljana Milosavljevic-Ristic, Guoqiao Wang, Michel Bottlaender, Roger Clarnette, Shauna H. Yuan, Raquel Sánchez-Valle, Russ C. Hornbeck, Ging-Yuek Robin Hsiung, Gregory Klein, Clifford R. Jack, Colin L. Masters, Nelly Joseph-Mathurin, Bruno Dubois, Barbara J. Snider, Shaney Flores, Douglas Galasko, David Wallon, Chengjie Xiong, Tammie L.S. Benzinger, Stephen Salloway, Christopher H. van Dyck, Sarah B. Berman, Brian A. Gordon, Catherine J. Mummery, Michael J. Fulham, John C. Morris, Yi Su, John M. Ringman, Randall J. Bateman, Jared R. Brosch, Martin R. Farlow, Benjamin Speidel, Suman Jayadev, Erik D. Roberson, Didier Hannequin, Lawrence S. Honig, Eric McDade, Mario Masellis
Publikováno v:
Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring
Alzheimer's & dementia (Amsterdam, Netherlands), vol 11, iss 1
Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, Vol 11, Iss 1, Pp 180-190 (2019)
Alzheimer's & dementia (Amsterdam, Netherlands), vol 11, iss 1
Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, Vol 11, Iss 1, Pp 180-190 (2019)
Introduction Quantitative in vivo measurement of brain amyloid burden is important for both research and clinical purposes. However, the existence of multiple imaging tracers presents challenges to the interpretation of such measurements. This study
Autor:
Tharick A. Pascoal, Serge Gauthier, Michael Schöll, Jean-Paul Soucy, Melissa Savard, Paul Edison, Mira Chamoun, Min Su Kang, Henrik Zetterberg, Gassan Massarweh, Nicholas J. Ashton, Kaj Blennow, Cecile Tissot, Jenna Stevenson, Joseph Therriault, Pedro Rosa-Neto, Mony J. de Leon, Andrea Lessa Benedet, Firoza Z. Lussier, Julie Ottoy, Thomas K. Karikari, Sulantha Mathotaarachchi
Publikováno v:
Nature Medicine. 27:2048-2049